For the treatment of non-metastatic (WHO staging):
1. Cutaneous mast cell tumours (located anywhere on the body, legs or head in dogs), and
2. Subcutaneous mast cell tumours located at or distal to the elbow or hock in dogs.
Tumours may be of any cytological grade, must be less than or equal to 10 cm3 in volume and must be accessible to intratumoural injection
KEY CHARACTERISTICS
BENEFITS
For the veterinarian:
For the pet owner:
Pack Size: 2 mL single use vial.
1. Cutaneous mast cell tumours (located anywhere on the body, legs or head in dogs), and
2. Subcutaneous mast cell tumours located at or distal to the elbow or hock in dogs.
Tumours may be of any cytological grade, must be less than or equal to 10 cm3 in volume and must be accessible to intratumoural injection
KEY CHARACTERISTICS
- Single treatment delivers complete response in 75% of canine mast cell tumours (MCTs).
- Removes 87% of MCTs after either one or two treatments.
- 89% of dogs have no tumour recurrence at the site of STELFONTA treatment at 12 months.
- Starts working within hours and the tumour is typically removed by Day 7, allowing a quick return to good quality of life.
- Destroys tumours via a three-fold mechanism. It has an oncolytic effect on tumour cells, induces an acute inflammatory response at the tumour site and directly destroys tumour vasculature, through a new targeted mode of action (Protein kinase C activator).
- Tumour site heals via second intention, with minimal intervention, typically within 6 weeks following tumour destruction (>50% within 28 days).
- Well-tolerated, main adverse events (wound formation) are related to mode of action and are indicators of efficacy
BENEFITS
For the veterinarian:
- High efficacy for treatment of MCTs without surgical or anaesthetic* risks.
- Local injection provides precise dosage and no specialised equipment is required.
- Provides an alternative to surgery where surgery is not a good option due to patient concerns (anaesthetic risk or tumour in a location that would require limb amputation to remove fully).
For the pet owner:
- Provides a non-surgical solution that avoids a hospital stay, usually without anaesthesia* and its associated risks.
- Minimal side effects: local wound and moderate pain for a few days.
- Hands-off healing with minimal scarring and good hair regrowth. Complete healing in 28 days in most cases.
- Return to normal mobility, fast improvement in quality of life after treatment.
Pack Size: 2 mL single use vial.
- [Zebravet_Files]:
- [Zebravet_Files]
- Categorisation:
- Presecription
Related Products
Footer Start
Braeside VIC 3195
AUSTRALIA
42 Kiln Street
Darra QLD 4076
AUSTRALIA